Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

NovoNordisk _ NN8640-4515

Study Phase: Observational

Condition(s): Growth Hormone Deficiency
A multi-national, multi-centre, prospective, single-arm, observational, non-interventional postauthorisation safety study to investigate long-term safety of Sogroya® (somapacitan) in adults with growth hormone deficiency (AGHD) under routine clinical practice

Primary Objective

To investigate long-term safety of Sogroya® (somapacitan) therapy in patients with AGHD in the setting of routine clinical practice with special focus on neoplasms and diabetes mellitus type 2.


Eligibility Criteria

  1. Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  2. The decision to initiate treatment with commercially available Sogroya® (somapacitan) has been made by the patient and the treating physician before and from the decision to include the patient in this study.
  3. Male or female, age above or equal to 18 years assigned to Sogroya® (somapacitan) treatment at the time of signing informed consent.
  4. Diagnosis of adult growth hormone deficiency (AGHD) as per local practice.
Jena Hagerty

Jena Hagerty

Primary Contact - Study Coordinator

484-464-0767
jena.hagerty@sluhn.org

548

Bankim A. Bhatt, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today